Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, Carlo, Lee, Virginia M.-Y., Trojanowski, John Q.·2007·Nature Reviews Neuroscience

DOI 10.1038/nrn2194

Cited by (1,014)

Items 201–300 of 1,014

Reactive astrocytes in Alzheimer’s disease: A double-edged sword
Chun, Heejung, Lee, C. Justin · 2018 · Neuroscience Research
The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule
Daniel Carneiro Carrettiero, Israel Hernández, Pierre A. Neveu, Thales Y. Papagiannakopoulos, Kenneth S. Kosik · 2009 · Journal of Neuroscience
The Chemical Neurobiology of Carbohydrates
Heather E. Murrey, Linda C. Hsieh‐Wilson · 2008 · Chemical Reviews
Alzheimer disease pathology as a host response
Castellani, Rudy J., Lee, Hyoung-gon, Zhu, Xiongwei, Perry, George, Smith, Mark A. · 2008 · Journal of Neuropathology & Experimental Neurology
Oleuropein and derivatives from olives as Tau aggregation inhibitors
Anthony Daccache, Cedric J. Lion, Nathalie Sibille, Melanie Gérard, Christian Slomianny, Guy M. Lippens, Philippe Cotelle · 2011 · Neurochemistry International
Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
Ashley N. Nilson, Kelsey C. English, Julia E. Gerson, T. Barton Whittle, C. Nicolas Crain, Judy J Xue, Urmi Sengupta, Diana Laura Castillo‐Carranza, Wenbo Zhang, Praveena K. Gupta et al. · 2016 · Journal of Alzheimer s Disease
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Raymond Farah, Hayat Haraty, Ziad Salame, Youssef Fares, David M. Ojcius, Najwane Said Sadier · 2018 · Biomedical Journal
Nonhuman Primate Models of Alzheimer-Like Cerebral Proteopathy
Heuer, Eric, F. Rosen, Rebecca, Cintron, Amarallys, C. Walker, Lary · 2012 · Current Pharmaceutical Design
Tau PET Imaging in Alzheimer’s Disease
Nobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, Hiroyuki Arai, Kazuhiko Yanai, Yukitsuka Kudo · 2014 · Current Neurology and Neuroscience Reports
Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species
Eliana Nachman, Anne S. Wentink, Karine Madiona, Luc Bousset, Taxiarchis Katsinelos, Kieren S. J. Allinson, Harm H. Kampinga, William A. McEwan, Thomas Robert Jahn, Ronald Melki et al. · 2020 · Journal of Biological Chemistry
Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer’s Disease
Jahangard, Yavar, Monfared, Hamideh, Moradi, Arman, Zare, Meysam, Mirnajafi-Zadeh, Javad, Mowla, Seyed Javad · 2020 · Frontiers in Neuroscience
Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of A lzheimer's Disease
Cheril Tapia‐Rojas, Florencia C. Aránguiz, Lorena Varela‐Nallar, Nibaldo C. Inestrosa · 2015 · Brain Pathology
Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons
Dennis Janning, Maxim Igaev, Frederik Sündermann, Jörg Brühmann, Oliver Beutel, Jürgen J. Heinisch, Lidia Bakota, Jacob Piehler, Wolfgang Junge, Roland Brandt · 2014 · Molecular Biology of the Cell
Tau exacerbates excitotoxic brain damage in an animal model of stroke
Bi, Mian, Gladbach, Amadeus, van Eersel, Janet, Ittner, Arne, Przybyla, Magdalena, van Hummel, Annika, Chua, Sook Wern, van der Hoven, Julia, Lee, Wei S., Müller, Julius et al. · 2017 · Nature Communications
Degradation of tau protein by autophagy and proteasomal pathways
Wang, Yipeng, Mandelkow, Eckhard · 2012 · Biochemical Society Transactions
Tau and Tauopathies
Gloria S. Lee, Chad J. Leugers · 2012 · Progress in molecular biology and translational science
Tau Mutations in Neurodegenerative Diseases
Michael S. Wolfe · 2008 · Journal of Biological Chemistry
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
Sofie Sølvsten Sørensen, Ann‐Britt Nygaard, Thomas Christensen · 2016 · Translational Neurodegeneration
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, Aseel, Mhatre, Isha, Richardson, Jason R. · 2019 · Pharmacology & Therapeutics
Why size matters – balancing mitochondrial dynamics in Alzheimer's disease
Brian DuBoff, Mel Β. Feany, Jürgen Götz · 2013 · Trends in Neurosciences
Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration
Merkwirth, Carsten, Martinelli, Paola, Korwitz, Anne, Morbin, Michela, Brönneke, Hella S., Jordan, Sabine D., Rugarli, Elena I., Langer, Thomas · 2012 · PLoS Genetics
Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?
Aleksandar Peric, Wim G. Annaert · 2015 · Acta Neuropathologica
The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
Johanna L. Crimins, Amy M. Pooler, Manuela Polydoro, Jennifer Irene Luebke, Tara L. Spires‐Jones · 2013 · Ageing Research Reviews
The role of extracellular Tau in the spreading of neurofibrillary pathology
Medina, Miguel, Avila, JesÃºs · 2014 · Frontiers in Cellular Neuroscience
Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment
Sohn, Peter Dongmin, Tracy, Tara E., Son, Hye-In, Zhou, Yungui, Leite, Renata E. P., Miller, Bruce L., Seeley, William W., Grinberg, Lea T., Gan, Li · 2016 · Molecular Neurodegeneration
Tau Oligomers and Fibrils Induce Activation of Microglial Cells
Morales, Inelia, Jiménez, José M., Mancilla, Marcela, Maccioni, Ricardo B. · 2013 · Journal of Alzheimer’s Disease
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
Kurt R. Brunden, Yuemang Yao, Justin S. Potuzak, Nuria Ibarz Ferrer, Carlo Ballatore, Michael J. James, Anne‐Marie L. Hogan, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee · 2010 · Pharmacological Research
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury
Sandy R. Shultz, David K. Wright, Ping Zheng, Ryan Stuchbery, Shi-Jie Liu, Maithili Sashindranath, Robert Lindsay Medcalf, Leigh A. Johnston, Christopher M. Hovens, Nigel C. Jones et al. · 2015 · Brain
Protein aggregation: Mechanisms and functional consequences
Gaetano Invernizzi, Elena Papaleo, Raimon Sabaté, Salvador Ventura · 2012 · The International Journal of Biochemistry & Cell Biology
Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease
Paul H. Axelsen, Hiroaki Komatsu, Ian V.J. Murray · 2011 · Physiology
Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease
Marius Chiasseu, Luis Alarcón-Martínez, Nicolás Belforte, Heberto Quintero, Florence Dotigny, Laurie Destroismaisons, Christine Vande Velde, Fany Panayi, Caroline Louis, Adriana Di Polo · 2017 · Molecular Neurodegeneration
Amyloidogenesis of Tau protein
Bartosz Niżyński, Wojciech Dzwolak, Krzysztof Nieznański · 2017 · Protein Science
Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behavior
Gaurav Ghag, Nemil N. Bhatt, Daniel V Cantu, Marcos Jair Guerrero‐Munoz, Anna Ellsworth, Urmi Sengupta, Rakez Kayed · 2018 · Protein Science
The basis of cellular and regional vulnerability in Alzheimer’s disease
Dunja Mrdjen, Edward J. Fox, Syed Abbas Bukhari, Kathleen S. Montine, Sean C. Bendall, Thomas Jude Montine · 2019 · Acta Neuropathologica
Tauopathy with paired helical filaments in an aged chimpanzee
Rosen, Rebecca F., Farberg, Aaron S., Gearing, Marla, Dooyema, Jeromy, M. Long, Patrick, Anderson, Daniel C., Davis‐Turak, Jeremy, Coppola, Giovanni, Geschwind, Daniel H., Paré, Jean‐Francois et al. · 2008 · Journal of Comparative Neurology
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins
Grant T. Corbett, Zemin Wang, Wei Hong, Martí Colom‐Cadena, Jamie L. Rose, Meichen Liao, Adhana Asfaw, Tia C. Hall, Lai Ding, Alexandra DeSousa et al. · 2019 · Acta Neuropathologica
Developments of CRBN-based PROTACs as potential therapeutic agents
Chao Wang, Yujing Zhang, Yudong Wu, Dongming Xing · 2021 · European Journal of Medicinal Chemistry
Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
Katharina Tepper, Jacek Biernat, Satish Kumar, Susanne Wegmann, Thomas Timm, Sabrina Hübschmann, Lars Redecke, Eva‐Maria Mandelkow, Daniel J. Müller, Eckhard Mandelkow� · 2014 · Journal of Biological Chemistry
Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
Hiroki Hashimoto, Kazunori Kawamura, Nobuyuki Igarashi, Makoto Takei, Tomoya Fujishiro, Yoshiharu Aihara, Satoshi Shiomi, Masatoshi Muto, Takehito Ito, Kenji Furutsuka et al. · 2014 · Journal of Nuclear Medicine
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Philine Schneider, Harald Juergen Hampel, Katharina Büerger · 2009 · CNS Neuroscience & Therapeutics
Why the brain talks to itself: sources of error in emotional prediction
Gilbert, Daniel T., Wilson, Timothy D. · 2009 · Philosophical Transactions of the Royal Society B: Biological Sciences
Identification of an Aggregation-Prone Structure of Tau
Elbaum-Garfinkle, Shana, Rhoades, Elizabeth · 2012 · Journal of the American Chemical Society
Okadaic acid induced neurotoxicity: An emerging tool to study Alzheimer's disease pathology
Pradip Kumar Kamat, Shivika Rai, Chandishwar Nath · 2013 · NeuroToxicology
Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
Mithilesh Kumar Jha, Jong-Heon Kim, Gyun Jee Song, Won‐Ha Lee, In Kyu Lee, Ho‐Won Lee, Seong Soo A. An, SangYun Kim, Kyoungho Suk · 2017 · Progress in Neurobiology
Why Pleiotropic Interventions are Needed for Alzheimer's Disease
Sally Ann Frautschy, Greg M. Cole · 2010 · Molecular Neurobiology
Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment
Robert John Hatch, Wei Yan, Di Xia, Jürgen Götz · 2017 · Acta Neuropathologica
Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
Abhay P. Sagare, Robert D. Bell, Berislav V. Zloković · 2012 · Journal of Alzheimer s Disease
Secretase inhibitors and modulators for Alzheimer’s disease treatment
Taisuke Tomita · 2009 · Expert Review of Neurotherapeutics
The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
Jinmei Jin, Ye Wu, Jin‐Jiao Chen, Yiwen Shen, Lijun Zhang, Hong Zhang, Lili Chen, Hebao Yuan, Hongzhuan Chen, Weidong Zhang et al. · 2020 · Theranostics
SCA1-like Disease in Mice Expressing Wild-Type Ataxin-1 with a Serine to Aspartic Acid Replacement at Residue 776
Duvick, Lisa, Barnes, Justin, Ebner, Blake, Agrawal, Smita, Andresen, Michael, Lim, Janghoo, Giesler, Glenn J., Zoghbi, Huda Y., Orr, Harry T. · 2010 · Neuron
Role of Aβ in Alzheimer’s-related synaptic dysfunction
Huiqin Zhang, Xuefan Jiang, Lina Ma, Wei Wei, Zehui Li, Surui Chang, Jiayu Wen, Jiahui Sun, Hao Li · 2022 · Frontiers in Cell and Developmental Biology
Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation
Crowe, Alex, James, Michael J., Lee, Virginia M.-Y., Smith, Amos B., Trojanowski, John Q., Ballatore, Carlo, Brunden, Kurt R. · 2013 · Journal of Biological Chemistry
Wnt signaling in Alzheimer's disease: Up or down, that is the question
Rick A.C.M. Boonen, Paula van Tijn, Danica Živković · 2008 · Ageing Research Reviews
Sumoylation and human disease pathogenesis
Kevin D. Sarge, Ok-Kyong Park-Sarge · 2009 · Trends in Biochemical Sciences
Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1
Iijima-Ando, Kanae, Sekiya, Michiko, Maruko-Otake, Akiko, Ohtake, Yosuke, Suzuki, Emiko, Lu, Bingwei, Iijima, Koichi M. · 2012 · PLoS Genetics
Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
Heiko Braak, Henrik Zetterberg, Kelly Del Tredici, Kaj Blennow · 2013 · Acta Neuropathologica
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Thomas A. Bayer · 2013 · European Neuropsychopharmacology
A role for FKBP52 in tau protein function
Chambraud, Béatrice, Sardin, Elodie, Giustiniani, Julien, Dounane, Omar, Schumacher, Michael, Goedert, Michel, Baulieu, Etienne-Emile · 2010 · Proceedings of the National Academy of Sciences
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Chen, Dongmei, Zhang, Tao, Lee, Tae Ho · 2020 · Biomolecules
Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes
Ismael Santa‐María, Merina Varghese, Hanna Ksiȩżak-Reding, Anastasiya Dzhun, Jun Wang, Giulio Maria Pasinetti · 2012 · Journal of Biological Chemistry
Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein
Gayathri Ramachandran, Jayant B. Udgaonkar · 2011 · Journal of Biological Chemistry
Proteolytic processing of tau
Yipeng Wang, Sarika Garg, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2010 · Biochemical Society Transactions
Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture
Hans Zempel, Frank J.A. Dennissen, Yatender Kumar, Julia Luedtke, Jacek Biernat, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2017 · Journal of Biological Chemistry
Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies
Kontaxi, Christiana, Piccardo, Pedro, Gill, Andrew C. · 2017 · Frontiers in Molecular Biosciences
Formation and Propagation of Tau Oligomeric Seeds
Julia E. Gerson, Rakez Kayed · 2013 · Frontiers in Neurology
Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions
Franck R. Petry, Jérôme Pelletier, Alexis Bretteville, Françoise Morin, Frédéric Calon, Sébastien S. Hébert, Robert A. Whittington, Emmanuel Planel · 2014 · PLoS ONE
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration
Xuebao Zhang, Clement Y. Chow, Zarife Sahenk, Michael E. Shy, Miriam H. Meisler, Jun Li · 2008 · Brain
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Van der Jeugd, Ann, Hochgräfe, Katja, Ahmed, Tariq, Decker, Jochen M., Sydow, Astrid, Hofmann, Anne, Wu, Dan, Messing, Lars, Balschun, Detlef, D’Hooge, Rudi et al. · 2012 · Acta Neuropathologica
Repetitive mild traumatic brain injury with impact acceleration in the mouse: Multifocal axonopathy, neuroinflammation, and neurodegeneration in the visual system
Leyan Xu, Judy V. Nguyen, Mohamed Lehar, Adarsh Menon, Elizabeth Y Rha, John D. Arena, Jiwon Ryu, Nicholas Marsh‐Armstrong, Christina R. Marmarou, Vassilis E. Koliatsos · 2014 · Experimental Neurology
Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277)
X-Y Qin, C Cao, Niamh X. Cawley, T-T Liu, J Yuan, Y Peng Loh, Yong Cheng · 2016 · Molecular Psychiatry
A syn–anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well
Gerrit M. Daubner, Antoine Cléry, Sandrine Jayne, James Stévenin, Frédéric H.‐T. Allain · 2011 · The EMBO Journal
Amyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
Ana Lloret, Mari-Carmen Badía, Esther Giraldo, Gennady Ermak, Maria-Dolores Alonso, Federico Vicente Pallardó, Kelvin J.A. Davies, José Viña · 2011 · Journal of Alzheimer s Disease
Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits
Koutsodendris, Nicole, Blumenfeld, Jessica, Agrawal, Ayushi, Traglia, Michela, Grone, Brian, Zilberter, Misha, Yip, Oscar, Rao, Antara, Nelson, Maxine R., Hao, Yanxia et al. · 2023 · Nature Aging
N -glycan and Alzheimer's disease
Yasuhiko Kizuka, Shinobu Kitazume, Naoyuki Taniguchi · 2017 · Biochimica et Biophysica Acta (BBA) - General Subjects
Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases
Antonella Sferra, Francesco Nicita, Enrico Bertini · 2020 · International Journal of Molecular Sciences
3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
Choi, Se Hoon, Kim, Young Hye, Quinti, Luisa, Tanzi, Rudolph E., Kim, Doo Yeon · 2016 · Molecular Neurodegeneration
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging
Condello, Carlo, Yuan, Peng, Grutzendler, Jaime · 2018 · Biological Psychiatry
Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance
Jinliang Chen, Cheng Luo, Die Pu, Guoqiang Zhang, Yuxing Zhao, Yue Sun, Kexiang Zhao, Zhiyin Liao, Ankang Lv, Shiyu Zhu et al. · 2018 · Experimental Neurology
Macrocyclic β-Sheet Peptides That Inhibit the Aggregation of a Tau-Protein-Derived Hexapeptide
Jing Zheng, Cong Liu, Michael R. Sawaya, Vadla Balraju, Shafiullah Khan, R. Jeremy Woods, David S Eisenberg, Warren J. Goux, James S. Nowick · 2011 · Journal of the American Chemical Society
Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease
Hashimoto, Shoko, Saido, Takaomi C. · 2018 · Open Biology
Synaptic dysfunction and septin protein family members in neurodegenerative diseases
Mikael Marttinen, Kaisa M. A. Kurkinen, Hilkka S. Soininen, Annakaisa Haapasalo, Mikko O. Hiltunen · 2015 · Molecular Neurodegeneration
Chemical approaches to understanding O-GlcNAc glycosylation in the brain
Jessica E. Rexach, Peter M. Clark, Linda C. Hsieh‐Wilson · 2008 · Nature Chemical Biology
The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
Kokiko-Cochran, Olga N., Godbout, Jonathan P. · 2018 · Frontiers in Immunology
Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model
Zhong-Hao Zhang, Qiuyan Wu, Rui Zheng, Chen Chen, Yao Chen, Qiong Liu, Peter R. Hoffmann, Jiazuan Ni, Guo-Li Song · 2017 · Journal of Neuroscience
Hsp90 activator Aha1 drives production of pathological tau aggregates
Lindsey B. Shelton, Jeremy D. Baker, Dali Zheng, Leia E. Sullivan, Parth K. Solanki, Jack M. Webster, Zheying Sun, Jonathan J. Sabbagh, Bryce A. Nordhues, John Koren et al. · 2017 · Proceedings of the National Academy of Sciences
Tauopathy: A common mechanism for neurodegeneration and brain aging
Pampa Saha, Nilkantha Sen · 2019 · Mechanisms of Ageing and Development
The Role of the Lipid Bilayer in Tau Aggregation
Shana Elbaum‐Garfinkle, Trudy F. Ramlall, Elizabeth R. Rhoades · 2010 · Biophysical Journal
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Alison E. Mungenast, Sandra Siegert, Li‐Huei Tsai · 2015 · Molecular and Cellular Neuroscience
Tau‐targeted treatment strategies in Alzheimer's disease
Jürgen Götz, Arne Ittner, Lars Matthias Ittner · 2011 · British Journal of Pharmacology
Tau imaging in neurodegenerative diseases
Melanie Dani, David James Brooks, Paul Edison · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
Protein Disaggregation in Multicellular Organisms
Nadinath B. Nillegoda, Anne S. Wentink, Bernd Bukau · 2018 · Trends in Biochemical Sciences
Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments
Kurt R. Brunden, John Q. Trojanowski, Virginia M.‐Y. Lee · 2008 · Journal of Alzheimer s Disease
Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease
John Nicholas Lukens, Vivianna M. Van Deerlin, Christopher M. Clark, Sharon Xiangwen Xie, F Brad Johnson · 2009 · Alzheimer s & Dementia
Blocking Aβ 42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between Aβ and Tau Pathology
Salvatore Oddo, Antonella Caccamo, Bert Tseng, David Cheng, Vitaly Vasilevko, David H. Cribbs, Frank M. LaFerla · 2008 · Journal of Neuroscience
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
Miguel Medina, Juan José Garrido, Francisco G. Wandosell · 2011 · Frontiers in Molecular Neuroscience
Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer’s Disease
Dongmei Wang, Yajun Yang, Li Zhang, Xu Zhang, Fei-Fei Guan, Zhang Lian-feng · 2013 · International Journal of Molecular Sciences
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease
Andréa Lessa Benedet, Antoine Leuzy, Tharick Ali Pascoal, Nicholas James Ashton, Sulantha Sanjeewa Mathotaarachchi, Mélissa Savard, Joseph Therriault, Min Su Kang, Mira Chamoun, Michael Schöll et al. · 2020 · Brain
Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease
Sandeep K. Rai, Adriana Savastano, Priyanka Singh, Samrat Mukhopadhyay, Markus Zweckstetter · 2021 · Protein Science
Phosphorus Dendrimers Affect Alzheimer’s (Aβ1–28) Peptide and MAP-Tau Protein Aggregation
Tomasz Wasiak, Максим Йонов, Krzysztof Nieznański, Hanna Nieznańska, Oxana l. Klementieva, Meritxell Granell, Josep Cladera, Jean‐Pierre Majoral, Anne‐Marie Caminade, Barbara Klajnert‐Maculewicz · 2011 · Molecular Pharmaceutics
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, Hailin, Alam, Azeem, San, Chun-Yin, Eguchi, Shiori, Chen, Qian, Lian, Qingquan, Ma, Daqing · 2017 · Brain Research